Cargando…
Genome editing in the treatment of ocular diseases
Genome-editing technologies have ushered in a new era in gene therapy, providing novel therapeutic strategies for a wide range of diseases, including both genetic and nongenetic ocular diseases. These technologies offer new hope for patients suffering from previously untreatable conditions. The uniq...
Autores principales: | Choi, Elliot H., Suh, Susie, Sears, Avery E., Hołubowicz, Rafał, Kedhar, Sanjay R., Browne, Andrew W., Palczewski, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474087/ https://www.ncbi.nlm.nih.gov/pubmed/37524870 http://dx.doi.org/10.1038/s12276-023-01057-2 |
Ejemplares similares
-
Precision genome editing in the eye
por: Suh, Susie, et al.
Publicado: (2022) -
Eye on genome editing
por: Du, Samuel W., et al.
Publicado: (2023) -
Retinoids in the visual cycle: role of the retinal G protein-coupled receptor
por: Choi, Elliot H., et al.
Publicado: (2021) -
LRAT-specific domain facilitates Vitamin A metabolism by domain swapping in HRASLS
por: Golczak, Marcin, et al.
Publicado: (2014) -
In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration
por: Choi, Elliot H., et al.
Publicado: (2022)